Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A

By Aceto M.D.   Scates S.M.   Lowe J.A.   Martin B.R.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

The cannabinoid CB 1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2

By Darmani N.A.  

European Journal of Pharmacology, Vol. 430, Iss. 1, 2001-10 ,pp. : 49-58

Elsevier

Access to resources Recommend Favorite

Effects of the cannabinoid CB 1 receptor antagonist, SR141716A, after 9 -tetrahydrocannabinol withdrawal

By Beardsley P.M.   Martin B.R.  

European Journal of Pharmacology, Vol. 387, Iss. 1, 2000-11 ,pp. : 47-53

Elsevier

Access to resources Recommend Favorite

The cannabinoid CB 1 receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus

By Tzavara E.T.   Perry K.W.   Rodriguez D.E.   Bymaster F.P.   Nomikos G.G.  

European Journal of Pharmacology, Vol. 426, Iss. 3, 2001-08 ,pp. : 3-4

Elsevier

Access to resources Recommend Favorite

Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB₁ receptor antagonist

By Järbe Torbjörn   Harris Michele   Li Chen   Liu Qian   Makriyannis Alexandros  

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 35-45

Springer Publishing Company

Access to resources Recommend Favorite